![]() Very common (10% or more): Extrapyramidal symptoms (up to 45%), parkinsonism (up to 26%), akathisia (up to 21%), headache (up to 18%), somnolence (up to 10%)Ĭommon (1% to 10%): Dizziness, dystonia, other abnormal movement disorders, other extrapyramidal diseases, sedation The most frequently reported adverse effects were extrapyramidal symptoms, akathisia, nausea, vomiting, somnolence, and restlessness. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.Ĭheck with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: More commonĪpplies to cariprazine: oral capsule. These side effects may go away during treatment as your body adjusts to the medicine. Some side effects of cariprazine may occur that usually do not need medical attention. sores, ulcers, or white spots in the mouth or on the lips.red skin lesions, often with a purple center.rapid or worm-like movements of the tongue.Blistering, peeling, or loosening of the skin.inability to move the arms, legs, or facial muscles.Burning feeling in the chest or stomach.thoughts or attempts at killing oneself.fast, pounding, or irregular heartbeat or pulse.difficult, burning, or painful urination.uncontrolled movements, especially of the face, neck, arms, or legs.trouble with breathing, speaking, or swallowing.muscle trembling, jerking, or stiffness. ![]() increased blinking or spasms of the eyelid.Although not all of these side effects may occur, if they do occur they may need medical attention.Ĭheck with your doctor immediately if any of the following side effects occur while taking cariprazine: More common Serious side effects of VraylarĪlong with its needed effects, cariprazine (the active ingredient contained in Vraylar) may cause some unwanted effects. The safety and effectiveness of cariprazine have not been established in pediatric patients. Closely monitor all antidepressant-treated patients for clinical worsening, and for the emergence of suicidal thoughts and behaviors. Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Cariprazine is not approved for the treatment of patients with dementia-related psychosis. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |